Sugi Predict

Sugi Predict / Compounds / SCHEMBL7181098

SCHEMBL7181098

SCHEMBL7181098

COCCOc1ccc(PC(=O)c2c(C(F)(F)F)cccc2C(F)(F)F)c(C)c1.[LiH]

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CYP1A2 P05177 2/20 0.39
▸ CYP3A4 P08684 2/20 0.39
▸ CYP2C19 P33261 2/20 0.39
▸ CYP2D6 P10635 1/20 0.39
▸ MCL1 Q07820 2/20 0.38
▸ FFAR1 O14842 3/20 0.37
▸ HPGD P15428 2/20 0.36
▸ CYP2C9 P11712 1/20 0.36
▸ KDM4E B2RXH2 1/20 0.35
▸ TDP1 Q9NUW8 1/20 0.35
▸ MAOB P27338 2/20 0.35
▸ MAOA P21397 1/20 0.35
▸ MRGPRX4 Q96LA9 1/20 0.35
▸ PPARG P37231 1/20 0.35
▸ PPARD Q03181 1/20 0.35
▸ PPARA Q07869 1/20 0.35
▸ FFAR4 Q5NUL3 1/20 0.34
▸ HTT P42858 1/20 0.34
▸ PIM1 P11309 1/20 0.34
▸ PIM2 Q9P1W9 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7182421 0.90 KMT2A (0.40) CYP1A2CYP3A4CYP2C19CYP2D6MCL1
SCHEMBL7186968 0.90 CYP2D6 (0.41) CYP1A2CYP3A4CYP2C19CYP2D6MCL1
SCHEMBL7188240 0.89 FFAR1 (0.39) CYP1A2CYP3A4CYP2C19CYP2D6MCL1
SCHEMBL7182798 0.89 MRGPRX4 (0.39) CYP1A2CYP3A4CYP2C19CYP2D6HPGD
SCHEMBL7182314 0.88 THRA (0.44) CYP1A2CYP3A4CYP2C19CYP2D6PPARG
SCHEMBL7189202 0.88 KMT2A (0.42) CYP1A2CYP3A4CYP2C19CYP2D6HPGD
SCHEMBL7189209 0.87 PDK2 (0.42) CYP1A2CYP3A4CYP2C19CYP2D6MCL1
SCHEMBL7182716 0.87 THRA (0.46) CYP1A2CYP3A4CYP2C19CYP2D6CACNA1B
SCHEMBL7180390 0.86 MAOB (0.40) MAOB
SCHEMBL7188420 0.86 TDP1 (0.39) FFAR1HPGDKDM4ETDP1PPARG

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6579663-B2 Chemical intermediates such as lithium 2,6-dimethylbenzoyl phenylphosphine for preparation of acylphosphines, acylphosphine oxides or acylphosphine sulfides CIBA SPECIALTY CHEMICALS CORPORATION 2003-06-17 — — US disclosed
US-20020107413-A1 Organometallic monoacylarylphosphines WOLF JEAN-PIERRE (CH) 2002-08-08 — — US disclosed
US-6399805-B2 SUCH AS LITHIUM 2,6-DIMETHYLBENZOYLPHENYLPHOSPHINE, USE AS PHOTOINITIATORS IN PHOTOCURABLE COMPOSITIONS SUCH AS FOR PHOTOGRAPHIC PRODUCTION OF RELIEF IMAGES CIBA SPECIALTY CHEMICALS CORPORATION 2002-06-04 — — US disclosed
US-20010031898-A1 Organometallic monoacylarylphosphines CIBA SPECIALTY CHEMICALS CORP. 2001-10-18 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20020107413-A1 Organometallic monoacylarylphosphines CBR1, NAF1, DHCR24 CYP1A2 1595/4885CYP3A4 1652/4885CYP2C19 1820/4885
US-20010031898-A1 Organometallic monoacylarylphosphines NAF1, DHCR24, CBR1 CYP1A2 2020/4885CYP3A4 1881/4885CYP2C19 2313/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.